M1 macrophages are known to inhibit cancer progression, CD4+T-cells can recognize cancer antigens (Lin et al., 2019), CD8+T-cells can inhibit cancer metastasis (Joseph et al., 2021), and immune infiltration of T-cells can significantly influence the efficacy of immunotherapy (Borst et al., 2018). Here, CD4 is linked to cancer.